IGXT (Mkap $34 M) 2 US-Zulassungsanträge im 4Q + weiteres Produkt wartet auf FDA Zulassung (Seite 99)
eröffnet am 27.07.16 17:27:05 von
neuester Beitrag 21.03.24 14:04:18 von
neuester Beitrag 21.03.24 14:04:18 von
Beiträge: 1.197
ID: 1.235.830
ID: 1.235.830
Aufrufe heute: 0
Gesamt: 195.654
Gesamt: 195.654
Aktive User: 0
ISIN: US45822R1014 · WKN: A0RP0X
0,1490
EUR
0,00 %
0,0000 EUR
Letzter Kurs 20:52:53 L&S Exchange
Neuigkeiten
08.04.24 · globenewswire  |
05.04.24 · globenewswire |
21.03.24 · globenewswire |
14.03.24 · globenewswire |
Werte aus der Branche Pharmaindustrie
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 6,0000 | +25,00 | |
| 0,6994 | +19,86 | |
| 9,5000 | +18,75 | |
| 0,6400 | +18,52 | |
| 1,0900 | +14,74 |
| Wertpapier | Kurs | Perf. % |
|---|---|---|
| 0,8410 | -17,06 | |
| 9,7200 | -19,60 | |
| 4,0000 | -27,27 | |
| 2,7280 | -29,14 | |
| 14,510 | -32,32 |
Beitrag zu dieser Diskussion schreiben
Feedback
nach wie vor sehr viele shorts in der aktie.
die verkaufen massiv und ungeniert ins bid ... die warrants sind natürlich auch noch da.
einfach den sept abwarten, denke hier kommt noch einiges.
trend is nach wie vor intakt ...
Sep 06 0.92 0.94 0.89 393,179 145,092 36.90%
Sep 02 0.93 0.93 0.91 325,795 138,922 42.64%
schon nervig
die verkaufen massiv und ungeniert ins bid ... die warrants sind natürlich auch noch da.
einfach den sept abwarten, denke hier kommt noch einiges.
trend is nach wie vor intakt ...
Sep 06 0.92 0.94 0.89 393,179 145,092 36.90%
Sep 02 0.93 0.93 0.91 325,795 138,922 42.64%
schon nervig
Antwort auf Beitrag Nr.: 53.227.872 von MG-Invest am 07.09.16 16:38:08Es muß auch bald etwas passieren, die ersten nehmen schon Gewinne mit, die 90c müssen auf jeden Fall gehalten werden
Aber solang diese Shows neues Investorenvolk anlockt, ist doch alles im Grünen
Aber solang diese Shows neues Investorenvolk anlockt, ist doch alles im Grünen
Antwort auf Beitrag Nr.: 53.227.662 von allin123 am 07.09.16 16:16:09Da sieht man halt, wo die burnrate verballert wird....schöne presentation in N.Y.C. und dann mit´nem learjet nach L.A. zur nächsten Präsi...
Hauptsache da kommt auch mal was für die Aktionäre bei ´rum.....
Hauptsache da kommt auch mal was für die Aktionäre bei ´rum.....
falls jemand Zeit findet...
IntelGenx to Present at the 18th Annual Rodman & Renshaw Global Investment Conference and the 11th Annual Singular Research Conference
SAINT-LAURENT, CANADA -- (Marketwired) -- 09/07/16 -- IntelGenx Corp., (TSX VENTURE: IGX) (OTCQX: IGXT), today announced that Dr. Horst Zerbe, President and Chief Executive Officer, will present at two upcoming conferences. Also present and available for questions will be Andre Godin, Executive Vice-President and Chief Financial Officer.
Rodman & Renshaw 18th Annual Global Investment Conference
Date: Monday, September 12
Location: Lotte New York Palace Hotel, New York City
Presentation Time: 10:50 AM Eastern Time
11th Annual Singular Research Conference "Best of the Uncovereds"
Date: Thursday, September 22
Location: Luxe Sunset Boulevard Hotel, Los Angeles
IntelGenx to Present at the 18th Annual Rodman & Renshaw Global Investment Conference and the 11th Annual Singular Research Conference
SAINT-LAURENT, CANADA -- (Marketwired) -- 09/07/16 -- IntelGenx Corp., (TSX VENTURE: IGX) (OTCQX: IGXT), today announced that Dr. Horst Zerbe, President and Chief Executive Officer, will present at two upcoming conferences. Also present and available for questions will be Andre Godin, Executive Vice-President and Chief Financial Officer.
Rodman & Renshaw 18th Annual Global Investment Conference
Date: Monday, September 12
Location: Lotte New York Palace Hotel, New York City
Presentation Time: 10:50 AM Eastern Time
11th Annual Singular Research Conference "Best of the Uncovereds"
Date: Thursday, September 22
Location: Luxe Sunset Boulevard Hotel, Los Angeles
IntelGenx to Present at the 18th Annual Rodman & Renshaw
Global Investment Conference and the 11th Annual Singular Research Conference
http://www.finanznachrichten.de/nachrichten-2016-09/38514455…
Global Investment Conference and the 11th Annual Singular Research Conference
http://www.finanznachrichten.de/nachrichten-2016-09/38514455…
Trading Spotlight
Antwort auf Beitrag Nr.: 53.224.056 von illmatix am 07.09.16 10:21:17wenn sich die Effekte bewahrheiten bzw. wissenschaftlich fundiert wird, ist ein Tenbagger unser kleinstes Problem 
Was war gestern eigentlich beim Kurs los? Schaut nach den üblichen Schüttelspielchen aus? Es müsste so langsam mal wieder Richtung ~1$ gearbeitet werden
Was war gestern eigentlich beim Kurs los? Schaut nach den üblichen Schüttelspielchen aus? Es müsste so langsam mal wieder Richtung ~1$ gearbeitet werden
moin,
ausm yahoo board :
"Spoke with IGXT's IR today and learned a few things regarding Montelukast and why this is such a great opportunity. First of all Montelukask is now off patent so no royalites or commissions have to be paid for developing and commercialization. Secondly the results of PII study will be released on an ongoing basis so we can expect feedback as early as Q1 of 2017 and won't have to wait until Q4 2017. We know from the press release that the Montelukast VersaFilm samples had greatly increased delivery results vs. pills but what is also exciting is that after the clinical patients took Montelukast for only 2 months their memory improved significantly (see slide 13 in last presentation on their web site). Phase II study will measure and prove this in a more quantitive focus but these early indications are positive.
IR also said that they are receiving many emails from older people who are taking Montelukast for asthma or allergies and have noticed since taking it that they went from feeling lethargic and dopey to feeling sharp and energetic, and that there are no negatitive side effects. He was saying these people are convinced it's because of Montelukast and are investing in IGXT for that reason.
See Less"
http://finance.yahoo.com/quote/IGXT/community?p=IGXT
der punkt mit den patenten ist natürlich sehr wichtig, das thema wurde neulich fälschlich dargestellt. ( glaub bei investorshub )
grüße
ausm yahoo board :
"Spoke with IGXT's IR today and learned a few things regarding Montelukast and why this is such a great opportunity. First of all Montelukask is now off patent so no royalites or commissions have to be paid for developing and commercialization. Secondly the results of PII study will be released on an ongoing basis so we can expect feedback as early as Q1 of 2017 and won't have to wait until Q4 2017. We know from the press release that the Montelukast VersaFilm samples had greatly increased delivery results vs. pills but what is also exciting is that after the clinical patients took Montelukast for only 2 months their memory improved significantly (see slide 13 in last presentation on their web site). Phase II study will measure and prove this in a more quantitive focus but these early indications are positive.
IR also said that they are receiving many emails from older people who are taking Montelukast for asthma or allergies and have noticed since taking it that they went from feeling lethargic and dopey to feeling sharp and energetic, and that there are no negatitive side effects. He was saying these people are convinced it's because of Montelukast and are investing in IGXT for that reason.
See Less"
http://finance.yahoo.com/quote/IGXT/community?p=IGXT
der punkt mit den patenten ist natürlich sehr wichtig, das thema wurde neulich fälschlich dargestellt. ( glaub bei investorshub )
grüße
Antwort auf Beitrag Nr.: 53.218.803 von illmatix am 06.09.16 17:23:31
Oh, sorry! Das war fast simultan
Zitat von illmatix: so her miller schrieb:
"Last week 756,765 warrants were exercised. Giving us 6,474,358 still outstanding.
Dr. Zerbe mentioned on the conference call that the agreement with the major pharmaceutical is expected to be closed by the end of the third quarter. Regarding the 33 companies mentioned, he did not give a specific time period when these possible partnerships could be concluded.
Best regards,
Edward "
dann warten wir mal ...
Oh, sorry! Das war fast simultan
Antwort auf Beitrag Nr.: 53.208.162 von illmatix am 05.09.16 12:31:50
Danke!
Wahrscheinlich wird gerade fleißig weiter gewandelt
Zitat von illmatix: moin,
insgesamt waren es um die 7 mio. 10 % hat er ja für die letzt woche bestätigt.
ich werde ihn nochmal nach der gesamtzahl der gewandelten warrants fragen.
3 quartal ist war ja die ansage für den abschluss diverser partnerdeals ( je nachdem ):
"Above and beyond that, there are ongoing late-stage discussions with a global pharmaceutical company
for multiple products with the potential goal of finalizing a definitive agreement in the third quarter of 2016.
In addition to that, in October, we will present our services and capabilities at the CPhI Conference in
Barcelona, Spain.
"
das wäre ja dann ende september. es wird also ein heisser monat
grüßle
Danke!
Wahrscheinlich wird gerade fleißig weiter gewandelt
so her miller schrieb:
"Last week 756,765 warrants were exercised. Giving us 6,474,358 still outstanding.
Dr. Zerbe mentioned on the conference call that the agreement with the major pharmaceutical is expected to be closed by the end of the third quarter. Regarding the 33 companies mentioned, he did not give a specific time period when these possible partnerships could be concluded.
Best regards,
Edward "
dann warten wir mal ...
"Last week 756,765 warrants were exercised. Giving us 6,474,358 still outstanding.
Dr. Zerbe mentioned on the conference call that the agreement with the major pharmaceutical is expected to be closed by the end of the third quarter. Regarding the 33 companies mentioned, he did not give a specific time period when these possible partnerships could be concluded.
Best regards,
Edward "
dann warten wir mal ...
Durchsuchen
